Ido Agmon
Fortune : 11 045 $ au 31/05/2026
Fortune : 11 045 $ au 31/05/2026
Ido Agmon currently works at Purple Biotech Ltd., as Independent Director from 2016.
Mr. Agmon also formerly worked at Meytav Technological Enterprises Innovation Center Ltd., as Chief Executive Officer from 2009 to 2011, EZ Orthopedics Ltd., as Director, SphinxTech Ltd., as Director, CyToD Ltd., as Director, ATI Ashkelon Technological Industries Ltd., as Director-Business Development from 2007 to 2009, Pep2Life Ltd., as Director, and Aviv Bio-Invest, as Manager from 2014 to 2016.
Mr. Agmon received his undergraduate degree from Tel-Aviv University and Masters Business Admin degree from The Hebrew University of Jerusalem.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PURPLE BIOTECH LTD. 0,15 % | 18/03/2026 | 3 093 860 ( 0,15 % ) | 11 045 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| PURPLE BIOTECH LTD | Directeur/Membre du Conseil | 27/06/2016 |
| Sociétés | Poste | Fin |
|---|---|---|
Aviv Bio-Invest
Aviv Bio-Invest Financial ConglomeratesFinance Functions as investment fund | Corporate Officer/Principal | 01/01/2016 |
Meytav Technological Enterprises Innovation Center Ltd.
Meytav Technological Enterprises Innovation Center Ltd. Investment ManagersFinance Meytav is a venture capital investment manager following a hands-on investment approach. It focuses on early-stage businesses in the life sciences sector, particularly biopharmaceuticals and medical device technology. It provides a wide range of support services to their portfolio companies, including incubator space for two to three years, office services, strategic advisory, planning and budgeting assistance, and access to an established network of business partners. Meytav targets projects based on innovation in the medical field. It leverages their close proximity with Upper Galilee research centers including MIGAL, specialized in agriculture and biotechnology, and the Tel Hai Community College. Each project is structured as an independent company co-owned by the entrepreneurs, the financing partners and Meytav's holding company. It promotes the growth of their investee companies through IP portfolio development and the establishment of partnerships for R&D, clinical development, manufacturing and commercialization worldwide. | Directeur Général | 31/12/2011 |
ATI Ashkelon Technological Industries Ltd.
ATI Ashkelon Technological Industries Ltd. Investment ManagersFinance ATI invests in companies located in Israel. The firm focuses on healthcare and cleantech sectors. It participates in early stage capital requirements. | Corporate Officer/Principal | 01/01/2009 |
Pep2Life Ltd.
Pep2Life Ltd. Medical DistributorsDistribution Services Develops proprietary novel pro-angiogenic drugs | Directeur/Membre du Conseil | - |
SphinxTech Ltd.
SphinxTech Ltd. Medical SpecialtiesHealth Technology Develops and manufactures medical devices | Président | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Meytav Technological Enterprises Innovation Center Ltd.
Meytav Technological Enterprises Innovation Center Ltd. Investment ManagersFinance Meytav is a venture capital investment manager following a hands-on investment approach. It focuses on early-stage businesses in the life sciences sector, particularly biopharmaceuticals and medical device technology. It provides a wide range of support services to their portfolio companies, including incubator space for two to three years, office services, strategic advisory, planning and budgeting assistance, and access to an established network of business partners. Meytav targets projects based on innovation in the medical field. It leverages their close proximity with Upper Galilee research centers including MIGAL, specialized in agriculture and biotechnology, and the Tel Hai Community College. Each project is structured as an independent company co-owned by the entrepreneurs, the financing partners and Meytav's holding company. It promotes the growth of their investee companies through IP portfolio development and the establishment of partnerships for R&D, clinical development, manufacturing and commercialization worldwide. | Finance |
EZ Orthopedics Ltd.
EZ Orthopedics Ltd. Medical SpecialtiesHealth Technology Develops medical orthopedics devices | Health Technology |
SphinxTech Ltd.
SphinxTech Ltd. Medical SpecialtiesHealth Technology Develops and manufactures medical devices | Health Technology |
CyToD Ltd.
CyToD Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic approach to treat such chronic asthma and rheumatoid arthritis | Health Technology |
ATI Ashkelon Technological Industries Ltd.
ATI Ashkelon Technological Industries Ltd. Investment ManagersFinance ATI invests in companies located in Israel. The firm focuses on healthcare and cleantech sectors. It participates in early stage capital requirements. | Finance |
Pep2Life Ltd.
Pep2Life Ltd. Medical DistributorsDistribution Services Develops proprietary novel pro-angiogenic drugs | Distribution Services |
Purple Biotech Ltd.
Purple Biotech Ltd. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drug discovery and development services | Health Technology |
Aviv Bio-Invest
Aviv Bio-Invest Financial ConglomeratesFinance Functions as investment fund | Finance |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national